[EN] HISTONE DEACETYLASE INHIBITORS<br/>[FR] INHIBITEURS DE L'HISTONE DÉSACÉTYLASE
申请人:UNIV QUEENSLAND
公开号:WO2022133551A1
公开(公告)日:2022-06-30
The present application is directed towards compounds, pharmaceutically acceptable salts or prodrugs thereof, which are inhibitors of Histone Deacetylase (HDAC) binding or function. The compounds especially may have some selectivity for inhibiting Class IIa versus Class I HDACs. The present application also relates to methods of using the compounds and to uses of the compounds, especially in relation to the prevention of a disease, disorder or condition associated with Class IIa HDAC activity. In one form, the compounds are (ortho-phenyl) phenyl hydroxamates. In another form, the compounds are as provided in Formula (I), wherein R1 is a phenyl or cycloalkenyl which may be optionally substituted. Formula (I)
本申请涉及抑制组蛋白去乙酰化酶(HDAC)结合或功能的化合物,药学上可接受的盐或其前药。这些化合物可能具有一定的选择性,能够抑制IIa类与I类HDAC。本申请还涉及使用这些化合物的方法和用途,尤其是与预防与IIa类HDAC活性相关的疾病、疾病或病情有关的用途。在一种形式中,这些化合物是(邻苯基)苯基羟肟酸酯。在另一种形式中,这些化合物如公式(I)所示,其中R1是苯基或环烯基,可选择性地取代。